Follow
sameer mirza
Title
Cited by
Cited by
Year
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins
S Mirza, G Sharma, R Parshad, SD Gupta, P Pandya, R Ralhan
Journal of breast cancer 16 (1), 23, 2013
2212013
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients
G Sharma, S Mirza, CP Prasad, A Srivastava, SD Gupta, R Ralhan
Life sciences 80 (20), 1873-1881, 2007
1552007
Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients
S Mirza, G Sharma, CP Prasad, R Parshad, A Srivastava, SD Gupta, ...
Life sciences 81 (4), 280-287, 2007
1542007
Epigenetic alterations of CDH1 and APC genes: Relationship with activation of Wnt/β-catenin Pathway in invasive ductal carcinoma of breast
CP Prasad, S Mirza, G Sharma, R Prashad, S DattaGupta, G Rath, ...
Life sciences 83 (9-10), 318-325, 2008
1302008
3D bioprinting of breast cancer models for drug resistance study
Y Wang, W Shi, M Kuss, S Mirza, D Qi, A Krasnoslobodtsev, J Zeng, ...
ACS biomaterials science & engineering 4 (12), 4401-4411, 2018
1242018
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients
G Sharma, S Mirza, R Parshad, A Srivastava, SD Gupta, P Pandya, ...
Life sciences 87 (3-4), 83-91, 2010
1052010
Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents
S Mirza, G Sharma, P Pandya, R Ralhan
Molecular and cellular biochemistry 342, 101-109, 2010
952010
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients
G Sharma, S Mirza, R Parshad, A Srivastava, SD Gupta, P Pandya, ...
Clinical biochemistry 43 (4-5), 373-379, 2010
922010
Detection of RASSF1A and RAR? Hypermethylation in Serum DNA from Breast Cancer Patients
S Shukla, S Mirza, G Sharma, R Parshad, SD Gupta, R Ralhan
Epigenetics 1 (2), 88-93, 2006
912006
Mouse models of estrogen receptor-positive breast cancer
S Mohibi, S Mirza, H Band, V Band
Journal of carcinogenesis 10, 2011
822011
DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients
G Sharma, S Mirza, R Parshad, SD Gupta, R Ralhan
Tumor Biology 33, 1837-1843, 2012
682012
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients
G Sharma, S Mirza, YH Yang, R Parshad, P Hazrah, S Datta Gupta, ...
Analytical Cellular Pathology 31 (6), 487-500, 2009
642009
Clinical significance of Stratifin, ERα and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients
S Mirza, G Sharma, R Parshad, A Srivastava, SD Gupta, R Ralhan
Clinical biochemistry 43 (4-5), 380-386, 2010
582010
3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition
Y Wang, S Mirza, S Wu, J Zeng, W Shi, H Band, V Band, B Duan
Oncotarget 9 (63), 32191, 2018
562018
Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 …
G Sharma, S Mirza, R Parshad, A Srivastava, SD Gupta, P Pandya, ...
Tumor Biology 32, 23-32, 2011
542011
Clinical Significance of Promoter Hypermethylation of ERβ and RARβ2 in Tumor and Serum DNA in Indian Breast Cancer Patients
S Mirza, G Sharma, R Parshad, A Srivastava, SD Gupta, R Ralhan
Annals of surgical oncology 19, 3107-3115, 2012
442012
Loss of the nuclear pool of ubiquitin ligase CHIP/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program
H Luan, B Mohapatra, TA Bielecki, I Mushtaq, S Mirza, TA Jennings, ...
Cancer research 78 (10), 2524-2535, 2018
412018
Mammalian alteration/deficiency in activation 3 (Ada3) is essential for embryonic development and cell cycle progression
S Mohibi, CB Gurumurthy, A Nag, J Wang, S Mirza, Y Mian, M Quinn, ...
Journal of Biological Chemistry 287 (35), 29442-29456, 2012
372012
Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention
R Ali, A Al-Kawaz, MS Toss, AR Green, IM Miligy, KA Mesquita, ...
Cancer Research 78 (24), 6818-6827, 2018
342018
Pan-cancer analysis reveals the diverse landscape of novel sense and antisense fusion transcripts
NN Vellichirammal, A Albahrani, JK Banwait, NK Mishra, Y Li, ...
Molecular Therapy-Nucleic Acids 19, 1379-1398, 2020
322020
The system can't perform the operation now. Try again later.
Articles 1–20